1. Academic Validation
  2. mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery

mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery

  • Nat Commun. 2025 May 6;16(1):4201. doi: 10.1038/s41467-025-59185-4.
Julia Hermann 1 2 Toman Borteçen 2 3 Robert Kalis 4 5 Alexander Kowar 2 6 Catarina Pechincha 1 2 Vivien Vogt 4 5 Martin Schneider 7 Dominic Helm 7 Jeroen Krijgsveld 3 Fabricio Loayza-Puch 6 Johannes Zuber 4 8 Wilhelm Palm 9
Affiliations

Affiliations

  • 1 Division of Cell Signaling and Metabolism, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • 2 Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • 3 Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 4 Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • 5 Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • 6 Translational Control and Metabolism Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 7 Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 8 Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • 9 Division of Cell Signaling and Metabolism, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany. w.palm@dkfz-heidelberg.de.
Abstract

Synthesizing the cellular proteome is a demanding process that is regulated by numerous signaling pathways and RNA modifications. How precisely these mechanisms control the protein synthesis machinery to generate specific proteome subsets remains unclear. Here, through genome-wide CRISPR screens we identify genes that enable mammalian cells to adapt to inactivation of the kinase mechanistic target of rapamycin complex 1 (mTORC1), the central driver of protein synthesis. When mTORC1 is inactive, Enzymes that modify tRNAs at wobble uridines (U34-enzymes), Elongator and Ctu1/2, become critically essential for cell growth in vitro and in tumors. By integrating quantitative nascent proteomics, steady-state proteomics and ribosome profiling, we demonstrate that the loss of U34-enzymes particularly impairs the synthesis of ribosomal proteins. However, when mTORC1 is active, this biosynthetic defect only mildly affects steady-state protein abundance. By contrast, simultaneous suppression of mTORC1 and U34-enzymes depletes cells of ribosomal proteins, globally inhibiting translation. Thus, mTORC1 cooperates with tRNA U34-enzymes to sustain the protein synthesis machinery and support the high translational requirements of cell growth.

Figures
Products